STAT July 8, 2024
Medical milestones broadcast via tweet. Scientific progress revealed via live YouTube demo. Teasers for updates followed by a livestream from a patient’s home. These aren’t the latest social media influencer tactics, but the way Neuralink, Elon Musk’s neurotechnology company, has disseminated information about its medical research.
Neuralink’s unconventional approaches to research have challenged many norms of medical science. Instead of attending scientific conferences and sharing interim progress, Neuralink has communicated information via social media, oscillating between extreme secrecy and openness. This strategy has left the scientific community playing catch-up, scrambling to glean insights from tweets and YouTube videos.
Rather than transparently sharing information about its ongoing clinical trial, Neuralink has kept details about it tightly guarded. The company’s unusual decision...